Home › Psychotic Disorders › Ohio › Parma
Psychotic Disorders clinical trials in Parma, OH
4 studies for Psychotic Disorders are looking for participants at sites in and around Parma (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
RecruitingPhase 2
- Clinical Site, Independence · 5 mi away
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
RecruitingPhase 3
- Insight Clinical Trials LLC - Independence, Independence · 5 mi away
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RecruitingPhase 4
- Neurocrine Clinical Site, Independence · 5 mi away
A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
RecruitingPhase 3
- Insight Clinical Trials LLC - Independence, Independence · 5 mi away
About Psychotic Disorders
Psychotic disorders are severe mental disorders that cause abnormal thinking and perceptions. Two main symptoms are delusions and hallucinations. Learn more.
More about Psychotic Disorders on MedlinePlus
Psychotic Disorders trials in other cities
- San Diego, CA10 studies
- Boston, MA9 studies
- New York City, NY7 studies
- Cambridge, MA6 studies
- Dallas, TX6 studies
- Queens, NY5 studies
- Miami, FL5 studies
- Los Angeles, CA5 studies
- Baltimore, MD4 studies
- Minneapolis, MN4 studies
- Anaheim, CA4 studies
- Tampa, FL4 studies
Other studies in Parma
- Ulcerative Colitis10 studies
- Crohn's Disease8 studies
- Steatotic Liver Disease7 studies
- Psoriatic Arthritis6 studies
- Lung Cancer5 studies
- Major Depressive Disorder5 studies
- Schizophrenia5 studies
- Endometrial Cancer4 studies
- Non-Small Cell Lung Cancer4 studies
- Ovarian Cancer4 studies
- Inflammatory Bowel Disease4 studies
- Alzheimer's Disease4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.